can semaglutide affect your heart A 2025 Lancet analysis of the SELECT trial concluded that reduced major adverse cardiovascular events by 20% in adults with overweight or obesity, regardless of how much weight patients actually lost Semaglutide and Cardiovascular Health |

It is in high demand and patients are seeking to find an available option

& Quarles, L

However, Sermorelin excels in promoting long-term metabolic improvements, which may lead to sustainable benefits over time

Tirzepatide causes more weight loss than semaglutide May 20, 2025 Summary: An 18-month study shows that tirzepatide (Zepbound) leads to more weight loss than semaglutide (Wegovy), although both are exceptionally effective at promoting clinically significant weight loss

The improvements in sperm count, provide hope that these medications can offer more than just metabolic benefits

That level of change alters the hormonal landscape substantially